Boothbay Fund Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-63,819
Closed -$8.42M 1941
2025
Q1
$8.42M Buy
+63,819
New +$7.95M 0.29% 102
2024
Q2
Sell
-5,700
Closed -$394K 1981
2024
Q1
$394K Buy
+5,700
New +$392K 0.01% 1097
2021
Q4
Sell
-19,851
Closed -$740K 2374
2021
Q3
$740K Sell
19,851
-19,219
-49% -$668K 0.03% 898
2021
Q2
$1.59M Hold
39,070
0.06% 485
2021
Q1
$1.33M Buy
39,070
+2,528
+7% +$87.7K 0.07% 478
2020
Q4
$1.16M Sell
36,542
-9,505
-21% -$250K 0.06% 445
2020
Q3
$1.18M Buy
+46,047
New +$1.05M 0.09% 380
2020
Q2
Sell
-61,884
Closed -$1.25M 1184
2020
Q1
$951K Buy
+61,884
New +$1.34M 0.1% 315
2018
Q4
Sell
-17,000
Closed -$369K 1000
2018
Q3
$369K Buy
+17,000
New +$355K 0.05% 452
2018
Q2
Sell
-11,300
Closed -$238K 998
2018
Q1
$238K Buy
+11,300
New +$220K 0.04% 553
2017
Q1
Sell
-12,303
Closed -$186 1009
2016
Q4
$186 Buy
+12,303
New +$174K 0.06% 617

Other funds holding ITCI